Answers are grounded in this paper and cite their sources.
: Drug-coated balloons (DCB) are a well-established option for treating in-stent restenosis endorsed by European Guidelines on myocardial revascularization. However, in recent years, a strategy of "leaving nothing behind" with DCB in de novo coronary stenosis has emerged as an appealing approach.
No takes yet. Share an insight, caveat, or question.
Sciahbasi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: